Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

MLTX US Equity

MoonLake ImmunotherapeuticsHealth Care · Pharmaceutical Preparations · CIK 1821586 · FY ends Dec 31
$16.74
+0.40 (+2.45%)
USD · as of 2026-08-19 · marketstack

MLTX · 10-K · period ended 2020-12-31

← all MLTX documents
filed 2021-03-31 · EDGAR original ↗

Our rendering of the filing — original pagination and typography are not reproduced, and tables are reduced to their short label cells (the figures live on FA). Nothing is summarized: every line below is the filing's own text.

blocks 1,7202,319 of 2,999293k characters rendered

ITEM 7. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL

CONDITION AND RESULTS OF OPERATIONS.

References to the “Company,” “Helix Acquisition

Corp.,” “our,” “us” or “we” refer to Helix Acquisition Corp. The following discussion

and analysis of the Company’s financial condition and results of operations should be read in conjunctionwith

the financial statements and the notes thereto contained elsewhere in this report. Certain information contained in the discussion

and analysis set forth below includes forward-looking statements that involve risks and uncertainties.

Cautionary

Note Regarding Forward-Looking Statements

This Annual Report on Form 10-K includes forward-looking

statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”),

and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). We have based these forward-looking

statements on our current expectations and projections about future events. These forward-looking statements are subject to known

and unknown risks, uncertainties and assumptions about us that may cause our actual results, levels of activity, performance or

achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied

by such forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as “may,”

“should,” “could,” “would,” “expect,” “plan,” “anticipate,”

“believe,” “estimate,” “continue,” or the negative of such terms or other similar expressions.

Such statements include, but are not limited to, possible business combinations and the financing thereof, and related matters,

as well as all other statements other than statements of historical fact included in this Form 10-K. Factors that might cause

or contribute to such a discrepancy include, but are not limited to, those described in our other Securities and Exchange Commission

(“SEC”) filings.

Overview

The following discussion and analysis

of the Company’s financial condition and results of operations should be read in conjunction with our audited financial

statements and the notes related thereto which are included in “Item 8. Financial Statements and Supplementary Data”

of this Annual Report on Form 10-K. Certain information contained in the discussion and analysis set forth below includes forward-looking

statements. Our actual results may differ materially from those anticipated in these forward-looking statements as a result of

many factors, including those set forth under “Special Note Regarding Forward-Looking Statements,” “Item 1A.

Risk Factors” and elsewhere in this Annual Report on Form 10-K.

We are a blank check company incorporated

in the Cayman Islands on August 13, 2020 formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition,

share purchase, reorganization or other similar business combination with one or more businesses. We intend to effectuate our business

combination using cash derived from the proceeds of the Public Offering and the sale of the Private Placement Shares, our shares,

debt or a combination of cash, shares and debt.

We expect to continue to incur significant

costs in the pursuit of our acquisition plans. We cannot assure you that our plans to complete a business combination will be successful.

Our sponsor is an

affiliate of Cormorant Asset Management, LP (“Cormorant”), a leading life sciences focused investment firm with

over $2 billion in assets under management as of June 30, 2020. Our registration statement

for the initial public offering (the “Initial Public Offering”) was declared effective on October 19, 2020.

On October 22, 2020, we consummated the Initial Public Offering of 115,000,000 Public

Sharesat $10.00 per Public Share, which included the full exercise by

the underwriters of their over-allotment option in the amount of 1,500,000 Public Shares, at $10.00 per Public Share, generating

gross proceeds of $115,000,000. We incurred total offering costs of approximately $6,325,000

in underwriting fees (inclusive of $4,025,000 million in deferred underwriting fees).

Simultaneously with the

closing of the Initial Public Offering, we consummated the private placement of 430,000 Private Placement Shares to

our Sponsor at a price of $10.00 per share, generating gross proceeds to the Company of $4,300,000.

Upon the closing of the Initial Public Offering and

the Private Placement, $115.0 million ($10.00 per Share) of the net proceeds of the Initial Public Offering and certain of the

proceeds of the Private Placement was placed in the Trust Account located in the United States with Continental

Stock Transfer & Trust Company acting as trustee, and is invested only in U.S. government securities, within the

meaning set forth in Section 2(a)(16) of the Investment Company Act, having a maturity of 185 days or less or in money

market funds meeting certain conditions under Rule 2a-7 promulgated under the Investment Company Act which invest only

in direct U.S. government treasury obligations, until the earlier of: (i) the completion of a business combination or (ii) the

distribution of the Trust Account as described below.

Our management has broad

discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of Private

Placement Shares, although substantially all of the net proceeds are intended to be applied generally toward consummating a business

combination.

If the Company is unable to complete a business combination

within 24 months from the closing of the Initial Public Offering, or October 22, 2022 (the “Combination Period”),

we will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not

more than ten business days thereafter, redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate

amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account and not previously

released to us (less taxes payable and up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding

Public Shares, which redemption will completely extinguish Public Shareholders’ rights as shareholders (including the right

to receive further liquidation distributions, if any) and (iii) as promptly as reasonably possible following such redemption,

subject to the approval of our remaining shareholders and our board of directors, liquidate and dissolve, subject, in the case

of clauses (ii) and (iii), to our obligations under Cayman Islands law to provide for claims of creditors and in all cases

subject to the other requirements of applicable law.

RESULTS OF OPERATIONS

Results of Operations

We

have neither engaged in any operations (other than searching for a business combination after our Initial Public Offering) nor

generated any operating revenues to date. Our only activities from inception through December 31, 2020 were organizational activities,

those necessary to prepare for the Initial Public Offering, described below, and, subsequent to the Initial Public Offering, identifying

a target company for a business combination. We do not expect to generate any operating revenues until after the completion of

our initial business combination. We expect to generate non-operating income in the form of interest income on marketable securities

held after the Initial Public Offering. We expect that we will incur increased expenses as a result of being a public company (for

legal, financial reporting, accounting and auditing compliance), as well as for due diligence expenses in connection with searching

for, and completing, a business combination.

For the period from August 13, 2020 (inception)

through December 31, 2020, we had a net loss of $90,838, which consisted of formation and operating costs of $105,755, offset by

interest earned on investments held in Trust Account of $14,917.

Liquidity and Capital Resources

Until the consummation of the Initial Public

Offering, our only source of liquidity was an initial purchase of ordinary shares by the Sponsor and loans from our Sponsor.

On October 22, 2020, we consummated the

Initial Public Offering of 11,500,000 Public Shares, which included the full exercise by the underwriters of their over-allotment

option in the amount of 1,500,000 Public Shares, at a price of $10.00 per Share, generating gross proceeds of $115,000,000. Simultaneously

with the closing of the Initial Public Offering, we consummated the sale of 430,000 Private Placement Shares to the Sponsor at

a price of $10.00 per Private Placement Share generating gross proceeds of $4,300,000.

Following the Initial Public Offering,

the full exercise of their over-allotment option and the sale of the Private Placement Shares, a total of $115,000,000 was placed

in the Trust Account. We incurred $6,750,447 in transaction costs, including $2,300,000 of underwriting fees, $4,025,000 of deferred

underwriting fees and $425,447 of other offering costs.

We intend to use substantially all of the

funds held in the Trust Account, including any amounts representing interest earned on the Trust Account, which interest shall

be net of taxes payable and excluding deferred underwriting commissions, to complete our business combination. We may withdraw

interest from the Trust Account to pay taxes, if any. To the extent that our share capital or debt is used, in whole or in part,

as consideration to complete a business combination, the remaining proceeds held in the Trust Account will be used as working capital

to finance the operations of the target business or businesses, make other acquisitions and pursue our growth strategies.

At December 31, 2020, we held $1,335,924

of cash outside of the Trust Account. We intend to use the funds held outside the Trust Account primarily to identify and evaluate

target businesses, perform business due diligence on prospective target businesses, travel to and from the offices, plants or similar

locations of prospective target businesses or their representatives or owners, review corporate documents and material agreements

of prospective target businesses, structure, negotiate and complete a business combination.

In order to fund working capital deficiencies

or finance transaction costs in connection with a business combination, our Sponsor or an affiliate of our Sponsor or certain of

our officers and directors may, but are not obligated to, loan us funds as may be required. If we complete a business combination,

we may repay such loaned amounts out of the proceeds of the Trust Account released to us. In the event that a business combination

does not close, we may use a portion of the working capital held outside the Trust Account to repay such loaned amounts, but no

proceeds from our Trust Account would be used for such repayment. Upon completion of a business combination, up to $1,500,000 of

such loans may be convertible into shares, at a price of $10.00 per share, at the option of the lender. The shares would be identical

to the Private Placement Shares.

We do not believe we will need to raise

additional funds in order to meet the expenditures required for operating our business. However, if our estimate of the costs of

identifying a target business, undertaking in-depth due diligence and negotiating a business combination are less than the actual

amount necessary to do so, we may have insufficient funds available to operate our business prior to our initial business combination.

Moreover, we may need to obtain additional financing either to complete our business combination or because we become obligated

to redeem a significant number of our public shares upon completion of our business combination, in which case we may issue additional

securities or incur debt in connection with such business combination.

Off-Balance Sheet Financing Arrangements

We have no obligations, assets or liabilities,

which would be considered off-balance sheet arrangements as of December 31, 2020. We do not participate in transactions that create

relationships with unconsolidated entities or financial partnerships, often referred to as variable interest entities, which would

have been established for the purpose of facilitating off-balance sheet arrangements. We have not entered into any off-balance

sheet financing arrangements, established any special purpose entities, guaranteed any debt or commitments of other entities, or

purchased any non-financial assets.

Contractual Obligations

We do not have any long-term debt, capital

lease obligations, operating lease obligations or long-term liabilities other than an agreement to pay the Sponsor a monthly fee

of $10,000 for office space, administrative services and remote support services provided to the Company. We began incurring these

fees on October 22, 2020 and will continue to incur these fees monthly until the earlier of the completion of a business combination

and the Company’s liquidation.

The underwriters are entitled to a deferred

fee of $0.35 per Share, or $4,025,000 in the aggregate. The deferred fee will become payable to the underwriters from the amounts

held in the Trust Account solely in the event that we complete a business combination, subject to the terms of the underwriting

agreement.

Critical Accounting Policies

The preparation of financial statements

and related disclosures in conformity with accounting principles generally accepted in the United States of America requires management

to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and

liabilities at the date of the financial statements, and income and expenses during the periods reported. Actual results could

materially differ from those estimates. We have not identified any critical accounting policies.

Class A Ordinary Shares Subject to Possible Redemption

We account for our ordinary shares subject

to possible redemption in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing

Liabilities from Equity.” Class A Ordinary shares subject to mandatory redemption is classified as a liability instrument

and is measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that features redemption rights

that is either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within

our control) is classified as temporary equity. At all other times, ordinary shares are classified as shareholders’ equity.

Our Class A ordinary shares feature certain redemption rights that are considered to be outside of our control and subject to occurrence

of uncertain future events. Accordingly, Class A ordinary shares subject to possible redemption is presented as temporary equity,

outside of the shareholders’ equity section of our balance sheet.

Net Income (Loss) per Ordinary Share

We apply the two-class method in calculating

earnings per share. Net income per ordinary share, basic and diluted for Class A redeemable ordinary shares is calculated by dividing

the interest income earned on the Trust Account by the weighted average number of Class A redeemable ordinary shares outstanding

since original issuance. Net loss per ordinary share, basic and diluted for Class B non-redeemable ordinary shares is calculated

by dividing the net income (loss), less income attributable to Class A redeemable ordinary shares, by the weighted average number

of Class B non-redeemable ordinary shares outstanding for the periods presented.

Recent Accounting Standards

Management does not believe that any other

recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on our financial

statements.

ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT

MARKET RISK.

We are a smaller reporting company

as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information otherwise required under this item.

ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA.

This information appears following Item 15 of this Report

and is included herein by reference.

HELIX ACQUISITION CORP.

TABLE OF CONTENTS

Report of Independent Registered Public Accounting Firm F-2

Financial Statements:

Balance Sheet F-3

Statement of Operations F-4

Statement of Changes in Shareholders’ Equity F-5

Statement of Cash Flows F-6

Notes to Financial Statements F-7 to F-13

REPORT OF INDEPENDENT REGISTERED PUBLIC

ACCOUNTING FIRM

To the Shareholders and the Board of Directors

of

Helix Acquisition Corp.

Opinion on the Financial Statements

We have audited the accompanying balance sheet of Helix Acquisition

Corp. (the “Company”) as of December 31, 2020, the related statements of operations, changes in shareholders’

equity and cash flows for the period from August 13, 2020 (inception) through December 31, 2020 and the related notes (collectively

referred to as the “financial statements”). In our opinion, the financial statements present fairly, in all material

respects, the financial position of the Company as of December 31, 2020, and the results of its operations and its cash flows for

the period from August 13, 2020 (inception) through December 31, 2020, in conformity with accounting principles generally accepted

in the United States of America.

Basis for Opinion

These financial statements are the responsibility

of the Company’s management. Our responsibility is to express an opinion on the Company’s financial statements based on our

audit. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (“PCAOB”)

and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable

rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audit in accordance with

the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether

the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have,

nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audit, we are required

to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the

effectiveness of the entity’s internal control over financial reporting. Accordingly, we express no such opinion.

Our audit included performing procedures

to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures

that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures

in the financial statements. Our audit also included evaluating the accounting principles used and significant estimates made by

management, as well as evaluating the overall presentation of the financial statements. We believe that our audit provides a reasonable

basis for our opinion.

/s/ WithumSmith+Brown, PC

We have served as the Company’s auditor

since 2020.

New York, New York

March 30, 2021

HELIX ACQUISITION CORP.

BALANCE SHEET

DECEMBER 31, 2020

ASSETS

Current assets

Cash and investments held in Trust Account 115,014,917

LIABILITIES AND SHAREHOLDERS’ EQUITY

Current liabilities

Promissory note- related party 58,063

Total Current Liabilities 125,183

Deferred underwriting fee payable 4,025,000

Commitments and Contingencies

Shareholders’ Equity

Additional paid-in capital 5,090,437

Accumulated deficit (90,838 )

Total Shareholders’ Equity 5,000,005

TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY $ 116,633,898

The accompanying notes are an integral part

of these financial statements.

HELIX ACQUISITION CORP.

STATEMENT OF OPERATIONS

FOR THE PERIOD FROM AUGUST 13, 2020 (INCEPTION)

THROUGH DECEMBER 31, 2020

Formation and operating costs $ 105,755

Loss from operations (105,755 )

Other income:

Interest earned on investments held in Trust Account 14,917

Basic and diluted net income per share, Class A $ —

Basic and diluted net loss per share, Class A and Class B $ (0.04 )

The accompanying notes are an integral part

of these financial statements.

HELIX ACQUISITION CORP.

STATEMENT OF CHANGES IN SHAREHOLDERS’

EQUITY

FOR THE PERIOD FROM AUGUST 13, 2020 (INCEPTION)

THROUGH DECEMBER 31, 2020

Shares Amount Shares Amount Capital Deficit Equity

Balance — August 13, 2020 (inception) — $ — — $ — $ — $ — $ —

The accompanying notes are an integral part

of these financial statements.

HELIX ACQUISITION CORP.

STATEMENT OF CASH FLOWS

FOR THE PERIOD FROM AUGUST 13, 2020 (INCEPTION)

THROUGH DECEMBER 31, 2020

Cash Flows from Operating Activities:

Adjustments to reconcile net loss to net cash used in operating activities:

Payment of formation costs through issuance of Class B ordinary shares 5,000

Interest earned on investments held in Trust Account (14,917 )

Changes in operating assets and liabilities:

Accounts payable and accrued expenses 67,120

Net cash used in operating activities (316,692 )

Cash Flows from Investing Activities:

Investment of cash in Trust Account (115,000,000 )

Net cash used in investing activities (115,000,000 )

Cash Flows from Financing Activities:

Proceeds from sale of Private Placement Shares 4,300,000

Payments of offering costs (347,384 )

Net cash provided by financing activities 116,652,616

Cash – Beginning —

Non-Cash Investing and Financing Activities:

Deferred underwriting fee payable $ 4,025,000

Offering costs paid through promissory note - related party $ 58,063

The accompanying notes are an integral part

of these financial statements.

HELIX ACQUISITION CORP.

NOTES TO FINANCIAL STATEMENTS

DECEMBER 31, 2020

NOTE 1 — DESCRIPTION

OF ORGANIZATION AND BUSINESS OPERATIONS

Helix Acquisition

Corp. (the “Company”) is a blank check company incorporated as a Cayman Islands exempted company on August 13,

2020. The Company was incorporated for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization

or similar business combination with one or more businesses or entities (a “Business Combination”).

The Company is not

limited to a particular industry or sector for purposes of consummating a Business Combination. The Company is an early stage and

emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth

companies.

As of December 31, 2020, the Company had

not commenced any operations. All activity for the period from August 13, 2020 (inception) through December 31, 2020 relates to

the Company’s formation and the initial public offering (“Initial Public Offering”), which is described below.

The Company will not generate any operating revenues until after the completion of a Business Combination, at the earliest. The

Company generates non-operating income in the form of interest income from the proceeds derived from the Initial Public Offering.

The registration statement

for the Company’s Initial Public Offering was declared effective on October 19, 2020. On October 22, 2020 the Company consummated

the Initial Public Offering of 11,500,000 Class A ordinary shares (the “Public Shares”) at $10.00 per Public Share,

which included the full exercise by the underwriters of their over-allotment option in the amount of 1,500,000 Public Shares, at

$10.00 per Public Share, generating gross proceeds of $115,000,000, which is described in Note 3.

Simultaneously with the closing of the Initial

Public Offering, the Company consummated the sale of 430,000 private placement Class A ordinary shares (the “Private Placement

Shares”) at a price of $10.00 per Private Placement Share in a private placement to Helix Holdings, LLC (the “Sponsor”),

generating gross proceeds of $4,300,000, which is described in Note 4.

Transaction costs

charged to equity amounted to $6,750,447, consisting of $2,300,000 of underwriting fees, $4,025,000 of deferred underwriting fees

and $425,447 of other offering costs.

Following the closing

of the Initial Public Offering on October 22, 2020, $115,000,000 ($10.00 per Public Share) from the net proceeds of the sale of

the Public Shares in the Initial Public Offering and the sale of the Private Placement Shares was placed in a trust account (the

“Trust Account”) and will be invested in U.S. government securities, within the meaning set forth in Section 2(a)(16)

of the Investment Company Act of 1940, as amended (the “Investment Company Act”), with a maturity of 185 days

or less, or in any open-ended investment company that holds itself out as a money market fund investing solely in U.S. Treasuries

and meeting certain conditions under Rule 2a-7 of the Investment Company Act, as determined by the Company, until the earliest

of: (i) the completion of a Business Combination and (ii) the distribution of the funds in the Trust Account to the Company’s

shareholders, as described below.

The Company’s

management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and

the sale of the Private Placement Shares, although substantially all of the net proceeds are intended to be applied generally toward

consummating a Business Combination. The stock exchange listing rules require that the Business Combination must be with one or

more operating businesses or assets with a fair market value equal to at least 80% of the assets held in the Trust Account (excluding

the amount of any deferred underwriting commissions and taxes payable on the income earned on the Trust Account). The Company will

only complete a Business Combination if the post-Business Combination company owns or acquires 50% or more of the issued and outstanding

voting securities of the target or otherwise acquires a controlling interest in the target business sufficient for it not to be

required to register as an investment company under the Investment Company Act. There is no assurance that the Company will be

able to successfully effect a Business Combination.

The Company provided

the holders of the public shares (the “Public Shareholders”) with the opportunity to redeem all or a portion of their

public shares upon the completion of the Business Combination, either (i) in connection with a general meeting called to approve

the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek shareholder

approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The Public

Shareholders will be entitled to redeem their Public Shares, equal to the aggregate amount then on deposit in the Trust Account,

calculated as of two business days prior to the consummation of the Business Combination (initially $10.00 per Public Share),

including interest (which interest shall be net of taxes payable), divided by the number of then issued and outstanding Public

Shares, subject to certain limitations as. The per-share amount to be distributed to the Public Shareholders who properly redeem

their shares will not be reduced by the deferred underwriting commissions the Company will pay to the underwriters (as discussed

in Note 6).

The Company will proceed

with a Business Combination only if the Company has net tangible assets of at least $5,000,001 and, if the Company seeks shareholder

approval, it receives an ordinary resolution under Cayman Islands law approving a Business Combination, which requires the affirmative

vote of a majority of the shareholders who attend and vote at a general meeting of the Company. If a shareholder vote is not required

and the Company does not decide to hold a shareholder vote for business or other legal reasons, the Company will, pursuant to its

Amended and Restated Memorandum and Articles of Association, conduct the redemptions pursuant to the tender offer rules of the

Securities and Exchange Commission (“SEC”), and file tender offer documents containing substantially the same information

as would be included in a proxy statement with the SEC prior to completing a Business Combination. If the Company seeks shareholder

approval in connection with a Business Combination, the Sponsor has agreed to vote the Founder Shares (as defined in Note 5) and

any Public Shares purchased during or after the Initial Public Offering in favor of approving a Business Combination. Additionally,

each Public Shareholder may elect to redeem their Public Shares, without voting, and if they do vote, irrespective of whether they

vote for or against a proposed Business Combination.

HELIX ACQUISITION CORP.

NOTES TO FINANCIAL STATEMENTS

DECEMBER 31, 2020

Notwithstanding the

foregoing, if the Company seeks shareholder approval of the Business Combination and the Company does not conduct redemptions pursuant

to the tender offer rules, a Public Shareholder, together with any affiliate of such shareholder or any other person with whom

such shareholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange

Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than

an aggregate of 20% of the Public Shares without the Company’s prior written consent.

The Sponsor has agreed

(a) to waive its redemption rights with respect to any Founder Shares, Private Placement Shares and Public Shares held by

it in connection with the completion of a Business Combination and (b) not to propose an amendment to the Amended and Restated

Memorandum and Articles of Association (i) to modify the substance or timing of the Company’s obligation to allow redemption

in connection with the Company’s initial Business Combination or to redeem 100% of the Public Shares if the Company does

not complete a Business Combination within the Combination Period (as defined below) or (ii) with respect to any other provision

relating to shareholders’ rights or pre-initial business combination activity, unless the Company provides the Public Shareholders

with the opportunity to redeem their Public Shares upon approval of any such amendment at a per-share price, payable in cash, equal

to the aggregate amount then on deposit in the Trust Account, including interest earned on the Trust Account and not previously

released to pay taxes, divided by the number of then issued and outstanding Public Shares.

The Company will have

until 24 months from the closing of the Initial Public Offering to consummate a Business Combination (the “Combination Period”).

However, if the Company has not completed a Business Combination within the Combination Period, the Company will (i) cease

all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business

days thereafter, redeem 100% of the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on

deposit in the Trust Account, including interest earned and not previously released to the Company to pay its taxes, if any (less

up to $100,000 of interest to pay dissolution expenses), divided by the number of then issued and outstanding Public Shares, which

redemption will completely extinguish the rights of the Public Shareholders as shareholders (including the right to receive further

liquidating distributions, if any), and (iii) as promptly as reasonably possible following such redemption, subject to the

approval of the Company’s remaining Public Shareholders and its Board of Directors, liquidate and dissolve, subject in each

case to the Company’s obligations under Cayman Islands law to provide for claims of creditors and the requirements of other

applicable law.

The Sponsor has agreed

to waive its rights to liquidating distributions from the Trust Account with respect to the Founder Shares and Private Placement

Shares it will receive if the Company fails to complete a Business Combination within the Combination Period. However, if the Sponsor

or any of its respective affiliates acquire Public Shares, such Public Shares will be entitled to liquidating distributions from

the Trust Account if the Company fails to complete a Business Combination within the Combination Period. The underwriters have

agreed to waive their rights to their deferred underwriting commission (see Note 6) held in the Trust Account in the event the

Company does not complete a Business Combination within the Combination Period, and in such event, such amounts will be included

with the other funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event

of such distribution, it is possible that the per share value of the assets remaining available for distribution will be less than

the Initial Public Offering price per Share ($10.00).

In order to protect

the amounts held in the Trust Account, the Sponsor has agreed that it will be liable to the Company if and to the extent any claims

by a third party (other than the Company’s independent registered public accounting firm) for services rendered or products

sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement,

reduce the amount of funds in the Trust Account to below the lesser of (1) $10.00 per Public Share and (2) the actual

amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account, if less than $10.00 per

Public Share, due to reductions in the value of trust assets, in each case net of the interest that may be withdrawn to pay taxes.

This liability will not apply to any claims by a third party who executed a waiver of any and all rights to seek access to the

Trust Account and as to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against

certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). In

the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the

extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have

to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (other than the

Company’s independent registered public accounting firm), prospective target businesses or other entities with which the

Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies

held in the Trust Account.

Liquidity and Capital Resources

As

of December 31, 2020, the Company had approximately $1.3 million in its operating bank accounts and working capital of approximately

$1.5 million.

Prior to the completion

of the Initial Public Offering, the Company’s liquidity needs had been satisfied through a contribution of $25,000 from

Sponsor to cover for certain offering costs in exchange for the issuance of the Founder Shares, the loan of up to $300,000 from

the Sponsor pursuant to the Note (see Note 5), and the proceeds from the consummation of the Private Placement not held in the

Trust Account. In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor or an

affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, provide the

Company Working Capital Loans (see Note 5). As of December 31, 2020, there were no amounts outstanding under any Working Capital

Loan.

HELIX ACQUISITION CORP.

NOTES TO FINANCIAL STATEMENTS

DECEMBER 31, 2020

Based on the foregoing,

management believes that the Company will have sufficient working capital and borrowing capacity to meet its needs through the

earlier of the consummation of a Business Combination or one year from this filing. Over this time period, the Company will be

using these funds for paying existing accounts payable, identifying and evaluating prospective initial Business Combination candidates,

performing due diligence on prospective target businesses, paying for travel expenditures, selecting the target business to merge

with or acquire, and structuring, negotiating and consummating the Business Combination.

NOTE 2 — SUMMARY

OF SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation

The accompanying

financial statements are presented in U.S. dollars and have been prepared in accordance with accounting principles generally accepted

in the United States of America (“U.S. GAAP”) and pursuant to the accounting and disclosure rules and regulations of

the Securities and Exchange Commission (the “SEC”).

Emerging Growth Company

The Company is an

“emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business

Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements

that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required

to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley

Act of 2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and

exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any

golden parachute payments not previously approved.

Further, Section 102(b)(1)

of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards

until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not

have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting

standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements

that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt

out of such extended transition period which means that when a standard is issued or revised and it has different application dates

for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time

private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with

another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using

the extended transition period difficult or impossible because of the potential differences in accounting standards used.

Use of Estimates

The preparation of

financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect

the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial

statements and the reported amounts of expenses during the reporting period.

Making estimates requires

management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition,

situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating

its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could

differ significantly from those estimates.

Cash and Cash Equivalents

The Company considers

all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company

did not have any cash equivalents as of December 31, 2020.

Offering Costs

Offering costs consist

of legal, accounting and other expenses incurred through the balance sheet date that are directly related to the Initial Public

Offering. Offering costs amounting to $6,750,447 were charged to shareholders’ equity upon the completion of the Initial

Public Offering (see Note 1).

Class A Ordinary Shares Subject to Possible

Redemption

The Company accounts for its

Class A ordinary shares subject to possible redemption in accordance with the guidance in Accounting Standards Codification

(“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” Class A ordinary shares subject to mandatory

redemption are classified as a liability instrument and are measured at fair value. Conditionally redeemable ordinary shares (including

ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon

the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other

times, ordinary shares are classified as shareholders’ equity. The Company’s Class A ordinary shares feature certain

redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future

events. Accordingly, at December 31, 2020, an aggregate of 10,748,371 Class A ordinary shares subject to possible redemption

are presented as temporary equity, outside of the shareholders’ equity section of the Company’s balance sheet.

HELIX ACQUISITION CORP.

NOTES TO FINANCIAL STATEMENTS

DECEMBER 31, 2020

Income Taxes

The Company accounts

for income taxes under ASC Topic 740, “Income Taxes,” which requires an asset and liability approach to financial accounting

and reporting for income taxes.

ASC Topic 740 prescribes

a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken

or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be

sustained upon examination by taxing authorities. The Company’s management determined that the Cayman Islands is the Company’s

major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax

expense. As of December 31, 2020, there were no unrecognized tax benefits and no amounts accrued for interest and penalties. The

Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation

from its position. The Company is subject to income tax examinations by major taxing authorities since inception.

The Company is considered

to be an exempted Cayman Islands company with no connection to any other taxable jurisdiction and is presently not subject to income

taxes or income tax filing requirements in the Cayman Islands or the United States. As such, the Company’s tax provision

was zero for the period presented. The Company’s management does not expect the total amount of unrecognized tax benefits

will materially change over the next twelve months.

Net Loss Per Ordinary Share

The Company’s

statement of operations includes a presentation of income (loss) per share for ordinary shares subject to possible redemption in

a manner similar to the two-class method of income (loss) per share. Net income per share, basic and diluted, for Class A redeemable

ordinary shares is calculated by dividing the interest income earned on the Trust Account, by the weighted average number of Class

A redeemable ordinary shares outstanding since original issuance. Net loss per share, basic and diluted, for Class B non-redeemable

ordinary shares is calculated by dividing the net loss, adjusted for income attributable to Class A redeemable ordinary shares,

by the weighted average number of Class B non-redeemable ordinary shares outstanding for the period. Class B non-redeemable ordinary

shares includes the Founder Shares as these shares do not have any redemption features and do not participate in the income earned

on the Trust Account.

The following table

reflects the calculation of basic and diluted net income (loss) per ordinary share (in dollars, except per share amounts):

For the Period from August 13, 2020 (inception) Through December 31, 2020

Redeemable Class A Ordinary Shares

Numerator: Earnings allocable to Redeemable Class A Ordinary Shares

Denominator: Weighted Average Redeemable Class A Ordinary Shares

Redeemable Class A Ordinary Shares, Basic and Diluted 11,500,000

Earnings/Basic and Diluted Redeemable Class A Ordinary Shares $ —

Non-Redeemable Class A and B Ordinary Shares

Numerator: Net Income (Loss) minus Redeemable Net Earnings

Redeemable Net Earnings $ (14,917 )

Non-Redeemable Net Loss $ (105,755 )

Denominator: Weighted Average Non-Redeemable Class A and B Ordinary Shares

Non-Redeemable Class A and B Ordinary Shares, Basic and Diluted (1) 2,920,522

Loss/Basic and Diluted Non-Redeemable Class A and B Ordinary Shares $ (0.04 )

As of December 31,

2020, basic and diluted shares are the same as there are no non-redeemable securities that are dilutive to the Company’s

ordinary shareholders.

HELIX ACQUISITION CORP.

NOTES TO FINANCIAL STATEMENTS

DECEMBER 31, 2020

Concentration of Credit Risk

Financial instruments

that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which,

at times, may exceed the Federal Depository Insurance Coverage of $250,000. The Company has not experienced losses on this account

and management believes the Company is not exposed to significant risks on such accounts.

Fair Value of Financial Instruments

The fair value of

the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 820, “Fair Value Measurement,”

approximates the carrying amounts represented in the Company’s balance sheet, primarily due to their short-term nature.

Recent Accounting Standards

Management does not

believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect

on the Company’s condensed financial statements.

NOTE 3 — INITIAL PUBLIC

OFFERING

Pursuant to the Initial

Public Offering, the Company sold 11,500,000 Public Shares, which included the full exercise by the underwriters of their over-allotment

option in the amount of 1,500,000 Public Shares, at a purchase price of $10.00 per Public Share generating gross proceeds

of $115,000,000.

NOTE 4 — PRIVATE PLACEMENT

Simultaneously with the closing of the Initial

Public Offering, the Sponsor purchased an aggregate of 430,000 Private Placement Class A Ordinary Shares at a price of $10.00 per

Private Placement Share, for an aggregate purchase price of $4,300,000. A portion of the proceeds from the Private Placement Shares

were added to the proceeds from the Initial Public Offering held in the Trust Account.

NOTE 5 — RELATED

PARTY TRANSACTIONS

Founder Shares

On August 19, 2020,

the Sponsor paid $25,000 to cover certain offering and formation costs of the Company in consideration for 3,593,750 Class B ordinary

shares. On September 30, 2020, the Sponsor surrendered, for no consideration, 718,750 Class B ordinary shares, resulting in the

Sponsor holding 2,875,000 Class B ordinary shares (the “Founder Shares”). In September 2020, the Sponsor transferred

30,000 Founder Shares to each of its independent directors. The Founder Shares included an aggregate of up to 375,000 shares that

were subject to forfeiture depending on the extent to which the underwriters’ over-allotment option was exercised, so that

the number of Founder Shares would equal, on an as-converted basis, approximately 20% of the Company’s issued and outstanding

ordinary shares after the Initial Public Offering (assuming the Sponsor did not purchase any Public Shares in the Initial Public

Offering and excluding the Private Placement Shares). As a result of the underwriters’ election to fully exercise their over-allotment

option, 375,000 Founder Shares are no longer subject to forfeiture.

The Sponsor and each

insider has agreed, subject to limited exceptions, not to transfer, assign or sell any of the Founder Shares or Private Placement

Shares until the earliest of: (A) one year after the completion of a Business Combination and (B) subsequent to a Business

Combination, (x) if the closing price of the Class A ordinary shares equals or exceeds $12.00 per share (as adjusted

for share sub-divisions, share dividends, rights issuances, reorganizations, recapitalizations and the like) for any 20 trading

days within any 30-trading day period commencing at least 150 days after a Business Combination, or (y) the date on which

the Company completes a liquidation, merger, share exchange or other similar transaction that results in all of the Public Shareholders

having the right to exchange their Class A ordinary shares for cash, securities or other property.

Administrative Services Agreement

Commencing on October 22, 2020, the Company

entered into an agreement to pay the Sponsor up to $10,000 per month for office space, utilities, administrative services and remote

support services. Upon completion of a Business Combination or its liquidation, the Company will cease paying these monthly fees.

As of December 31, 2020, the Company incurred and accrued $20,000 in fees for these services.

HELIX ACQUISITION CORP.

NOTES TO FINANCIAL STATEMENTS

DECEMBER 31, 2020

Promissory Note — Related

Party

On August 19, 2020,

the Company issued an unsecured promissory note (the “Promissory Note”) to the Sponsor, pursuant to which the Company

Source: SEC EDGAR (public domain) · 10-K for the period ended 2020-12-31, filed 2021-03-31 · accession 0001213900-21-019007

Filing HTML rendered to line-structured narrative text by the shipped reducer (datafeeds.edgar_fulltext.visible_text, keep_table_headers=True): scripts and inline-XBRL headers are dropped, and table content is reduced to its short label cells — numeric table data is not rendered and is therefore not counted. The same rendering is used for every year, so a year-over-year comparison is like for like.

The text is our rendering of the filing, not a facsimile: original pagination, typography and tables are not reproduced, and the numbers live in the financial statements (FA).

The outline locates item HEADINGS in this document. Only Items 1A and 7 have certified boundaries elsewhere in the terminal (the redline and the narrative-overlap number); every span here runs from one heading found to the next heading found.

How the outline was chosen. It is the longest chain of item headings that runs forward through both the document and the standard item order: 19 headings are on that chain and 14 further heading-shaped lines are not — the table-of-contents echo of every item, cross-references and exhibit-list mentions. Each entry's length is measured from its heading to the next heading on the chain.